Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have been diagnosed with multiple myeloma (MM), as confirmed by their treating doctor at the study site — people who also have a related condition called AL amyloidosis are still eligible
- People who have started at least a second round of treatment for multiple myeloma, and who have previously been treated with at least one type of drug from a group called proteasome inhibitors or one from a group called immunomodulatory drugs (confirm with trial site if unsure whether past treatments qualify)
Who may not be able to join:
- People whose doctor has determined they are terminally ill, meaning they are expected to have six months or less to live, or people who have moved to comfort-focused care only (care aimed at managing symptoms rather than treating the disease)
- People who have previously taken part in Pack Health digital health coaching
- People whose doctor has assessed that their English language skills are not sufficient to participate
- People who do not own a personal smartphone or device that allows access to text messages, email, or mobile apps
- People who have a serious or unstable medical, mental health, or other condition that could affect their safety, their ability to give informed consent, or their ability to follow the study procedures
- People who are already enrolled in another treatment-focused clinical trial for relapsed or refractory multiple myeloma that does not allow participation in additional studies at the same time
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rahul Banerjee, MD, University of Washington
Phone: 205-721-7542
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility of the Digital Health Coaching Intervention
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.